BCM
TFFP

Bridgeway Capital Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Bridgeway Capital Management’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-952
Closed -$16.3K – 1461
2023
Q1 		$16.3K Sell
952
-1,396
-59% -$30.2K ﹤0.01% 1362
2022
Q4 		$61.6K Hold
2,348
– – ﹤0.01% 1279
2022
Q3 		$238K Sell
2,348
-832
-26% -$113K 0.01% 1099
2022
Q2 		$449K Hold
3,180
– – 0.01% 903
2022
Q1 		$502K Hold
3,180
– – 0.01% 934
2021
Q4 		$705K Buy
3,180
+1,000
+46% +$194K 0.01% 880
2021
Q3 		$421K Buy
+2,180
New +$463K 0.01% 1081

Other funds holding TFFP

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bridgeway Capital Management's TFFP Position: Q2 2023 in Review

Bridgeway Capital Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q2 2023, closing a stake of 952 shares — an estimated $16.3K sold.

Bridgeway Capital Management first reported a position in TFFP in Q3 2021 and held it in 7 quarters. The position peaked at $705K in Q4 2021. 33 funds tracked by Wall St. Rank hold TFFP as of Q2 2023.

  • Bridgeway Capital Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 952 TFF Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $16.3K.
  • Bridgeway Capital Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
  • Bridgeway Capital Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $705K in Q4 2021.
  • 33 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.